Tocilizumab

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7798 publications

Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapies.

Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapies.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

Tocilizumab in melanoma: friend or foe?

Tocilizumab in melanoma: friend or foe?

Journal: Italian journal of dermatology and venereology
Published: April 08, 2026

Role of Tocilizumab in Severe CNS Inflammatory Presentations in Children.

Role of Tocilizumab in Severe CNS Inflammatory Presentations in Children.

Journal: Neurology
Published: April 07, 2026

Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.

Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.

Journal: Journal of internal medicine
Published: April 07, 2026

Treatment of Giant cell arteritis: focus on upadacitinib.

Treatment of Giant cell arteritis: focus on upadacitinib.

Journal: Expert opinion on pharmacotherapy
Published: April 02, 2026

Updates on Giant Cell Arteritis.

Updates on Giant Cell Arteritis.

Journal: Neurologic clinics
Published: April 01, 2026

Updates on Treatment in Thyroid Eye Disease for the Neurologist.

Updates on Treatment in Thyroid Eye Disease for the Neurologist.

Journal: Neurologic clinics
Published: April 01, 2026

Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease.

Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease.

Journal: Drug discoveries & therapeutics
Published: April 01, 2026

Considerations for infection risks identified in target safety review.

Considerations for infection risks identified in target safety review.

Journal: The Journal of toxicological sciences
Published: April 01, 2026

A Case Report of Successful Control of Refractory Tumor Fever 
in Lung Adenocarcinoma with Interleukin-6 Antibody Tocilizumab

A Case Report of Successful Control of Refractory Tumor Fever 
in Lung Adenocarcinoma with Interleukin-6 Antibody Tocilizumab

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: March 31, 2026

A Rare Case of Early-Onset Steroid-Refractory Fulminant Hepatitis Following Dual Checkpoint Inhibition in Melanoma Initially Presenting With Hemorrhagic Brain Metastasis.

A Rare Case of Early-Onset Steroid-Refractory Fulminant Hepatitis Following Dual Checkpoint Inhibition in Melanoma Initially Presenting With Hemorrhagic Brain Metastasis.

Journal: Journal of investigative medicine high impact case reports
Published: March 24, 2026

Racial and Ethnic Disparities in Severe Ischemic Manifestations and Tocilizumab Use Among Patients With Giant Cell Arteritis: A Nationwide Retrospective Cohort Study Using TriNetX.

Racial and Ethnic Disparities in Severe Ischemic Manifestations and Tocilizumab Use Among Patients With Giant Cell Arteritis: A Nationwide Retrospective Cohort Study Using TriNetX.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: March 24, 2026
Showing 1-12 of 7,798

Last Updated: 04/28/2026